Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (29 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 23 Dec 2021 – 20 Aug 2026, limited by Axis Multicap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Multicap Fund | Nifty 500 |
|---|---|---|
| 23 Dec 2021 | ₹100.00 | ₹100.00 |
| 14 May 2022 | ₹86.91 | ₹91.32 |
| 03 Oct 2022 | ₹97.50 | ₹99.23 |
| 21 Feb 2023 | ₹99.50 | ₹101.10 |
| 13 Jul 2023 | ₹113.99 | ₹112.69 |
| 02 Dec 2023 | ₹130.77 | ₹122.80 |
| 22 Apr 2024 | ₹149.95 | ₹139.48 |
| 10 Sep 2024 | ₹185.61 | ₹160.28 |
| 30 Jan 2025 | ₹170.63 | ₹144.38 |
| 21 Jun 2025 | ₹183.32 | ₹156.20 |
| 10 Nov 2025 | ₹191.21 | ₹159.96 |
| 31 Mar 2026 | ₹168.33 | ₹139.16 |
| 20 Aug 2026 | ₹199.90 | ₹159.39 |
| Metric | Axis · Direct · IDCW NAV ₹20.01 Very High risk ★★★★★ | Category median Multi Cap Fund · 29 funds |
|---|---|---|
| +6.55% | +6.55% | |
| +20.09% | +13.71% | |
| — | +12.07% | |
| — | +9.16% | |
| +16.04% | +14.55% | |
| +17.41% | — | |
| +22.76% | +17.33% | |
| — | +14.39% | |
| — | +9.74% | |
| Risk | ||
| 14.92% | 15.40% | |
| 0.91 | 0.41 | |
| 1.24 | 0.54 | |
| -18.14% | -21.00% | |
| Nifty 500 | — | |
| +6.53% | +1.30% | |
| 0.98 | 1.03 | |
| 115.4% | 104.7% | |
| 83.9% | 99.6% | |
| 1.10% | 0.93% | |
| ₹9,775Cr | ₹4,007Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 57% | 53% | |
| Sachin Jain | — | |
| 23 Dec 2021 | — | |
| 106 | — | |
| 24.0% | — | |
| -0.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.